Pay in 4 interest-free payments of $5.25 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Leslie Iverson, from Intermountain Health in Salt Lake City, and colleagues queried the Intermountain Health electronic medical records to examine whether GLP-1 RAs are associated with an increased risk for pancreatitis and major adverse cardiovascular events (MACE) in adults with type 2 diabetes and/or body mass index 27 kg/m 2 with and without hypertriglyceridemia
A., Olakkaran, S., Antony, A., Tilagul, K
Triple Agonist A compound that activates three different receptors
For patients with intolerance or contraindications to metformin, sulfonylurea monotherapy is recommended as first-line treatment with a similar subsequent treatment pathway when glycemic control is not attained [4]
Additionally, DPP-4 inhibitors may help protect against hypoglycemia by influencing pancreatic cells (19, 23)
US$ 20.61
US$ 27.88
US$ 25.30
US$ 19.98
US$ 22.55
US$ 21.28
US$ 29.70
